⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6337465 | 1.00 | — | — | |
| SCHEMBL22589402 | 0.75 | NOS3 (0.36) | — | |
| SCHEMBL1708937 | 0.75 | — | — | |
| SCHEMBL2933677 | 0.75 | — | — | |
| SCHEMBL2222898 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL4419382 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL11107945 | 0.73 | NOS3 (0.35) | — | |
| SCHEMBL6154815 | 0.73 | — | — | |
| SCHEMBL7360709 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL9034919 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4263491-A2 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NeuBase Therapeutics, Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| EP-4127228-A2 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | NeuBase Therapeutics, Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| WO-2022132194-A2 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NEUBASE THERAPEUTICS, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2021202621-A2 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | NEUBASE THERAPEUTICS, INC. (US) | 2021-10-07 | — | — | WO | disclosed |